We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+14.82%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.68B
AUM Growth
+$260M
Cap. Flow
-$333M
Cap. Flow %
-7.13%
Top 10 Hldgs %
66.49%
Holding
59
New
7
Increased
15
Reduced
18
Closed
15

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$173M
2
CTVA icon
Corteva
CTVA
+$121M
3
DXC icon
DXC Technology
DXC
+$72.8M
4
VTRS icon
Viatris
VTRS
+$58.1M
5
THC icon
Tenet Healthcare
THC
+$55.6M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$111M
2
APTV icon
Aptiv
APTV
+$81.2M
3
TFX icon
Teleflex
TFX
+$74.8M
4
INTC icon
Intel
INTC
+$70.9M
5
FISV
Fiserv Inc
FISV
+$40.1M

Sector Composition

Rank Sector Weight
1 Healthcare 44.98%
2 Technology 20.65%
3 Consumer Discretionary 7.14%
4 Industrials 6.91%
5 Materials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHTR icon
26
Charter Communications
CHTR
$18.8B
$45.4M 0.97%
116,933
-54,154
-32% -$22.1M
DNB
27
DELISTED
Dun & Bradstreet
DNB
$45.2M 0.97%
3,859,884
+1,655,510
+75% +$16.9M
BC icon
28
Brunswick
BC
$5.28B
$34.9M 0.75%
360,677
+105,327
+41% +$8.37M
EVLV icon
29
Evolv Technologies
EVLV
$1.07B
$26.4M 0.57%
5,599,039
+1,000,000
+22% +$4.27M
CAH icon
30
Cardinal Health
CAH
$55.7B
$20.5M 0.44%
203,254
-54,076
-21% -$5.37M
ELV icon
31
Elevance Health
ELV
$84.9B
$17.9M 0.38%
37,909
+22,982
+154% +$10.6M
INTC icon
32
Intel
INTC
$503B
$17.3M 0.37%
344,263
-1,744,329
-84% -$70.9M
TEVA icon
33
Teva Pharmaceuticals
TEVA
$40.6B
$16.8M 0.36%
+1,604,633
New +$15M
USFD icon
34
CALL
US Foods
USFD
$23.6B
$11.4M 0.24%
+250,000
New +$10.3M
MRVL icon
35
Marvell Technology
MRVL
$189B
$10.8M 0.23%
+179,709
New +$9.71M
DMRC icon
36
Digimarc Corp
DMRC
$171M
$10.5M 0.23%
291,855
-113,867
-28% -$3.61M
BFLY icon
37
Butterfly Network
BFLY
$2.21B
$8.68M 0.19%
8,033,501
– –
OFIX icon
38
Orthofix Medical
OFIX
$428M
$6.74M 0.14%
+500,000
New +$5.87M
LBTYA icon
39
Liberty Global Class A
LBTYA
$3.68B
$3.13M 0.07%
+176,110
New +$2.85M
CBUS icon
40
Cibus
CBUS
$143M
$2.29M 0.05%
116,465
-3,498
-3% -$51.9K
RPID icon
41
Rapid Micro Biosystems
RPID
$104M
$976K 0.02%
1,318,288
– –
DOMA
42
DELISTED
Doma Holdings, Inc.
DOMA
$74.1K ﹤0.01%
15,994
-4,000
-20% -$19.8K
BFLY.WS
43
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$60K ﹤0.01%
1,713,333
– –
APTV icon
44
Aptiv
APTV
$9.61B
– –
-823,537
Closed -$81.2M
AVTR icon
45
Avantor
AVTR
$8.91B
– –
-1,019,890
Closed -$21.5M
DD icon
46
DuPont de Nemours
DD
$19.5B
– –
-344,622
Closed -$32.3M
MASI
47
DELISTED
Masimo
MASI
– –
-208,848
Closed -$18.3M
MDT icon
48
Medtronic
MDT
$110B
– –
-179,928
Closed -$14.1M
MKSI icon
49
MKS Inc
MKSI
$19.7B
– –
-56,350
Closed -$4.88M
MSFT icon
50
Microsoft
MSFT
$3.71T
– –
-29,915
Closed -$9.45M
1
2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Glenview Capital Management held 59 positions worth $4.68B, up 5.9% from $4.42B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Glenview Capital Management withdrew a net $333M in Q4 2023, closing 15 positions and reducing 18 holdings. Its most notable exit was Activision Blizzard, an estimated $111M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Glenview Capital Management opened a new position in Viatris worth $65.7M.

  • Glenview Capital Management's largest Q4 2023 buy was Viatris: 6,065,047 shares worth $65.7M.
  • Glenview Capital Management added most to Cigna in Q4 2023, an estimated $173M increase.
  • Glenview Capital Management's biggest Q4 2023 reduction was Intel, cutting an estimated $70.9M.
  • Glenview Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $111M.
  • Glenview Capital Management's ten largest holdings make up 66% of its $4.68B portfolio in Q4 2023.
  • Glenview Capital Management opened 7 new positions and closed 15 in Q4 2023.
  • Glenview Capital Management's portfolio value rose 5.9% quarter-over-quarter to $4.68B.

Based on Glenview Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.